ArticlePharmaceutical research2022

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer.

Prashant Dogra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.